Earth Science Te Stock Price, News & Analysis

Earth Science Tech (OTC: ETST) engaged Hayden IR on Jan 5, 2026 to expand investor outreach, messaging, and market awareness after completing FINRA 15c-211 clearance. Hayden IR will support institutional and retail outreach, corporate access, and public disclosure support as ETST scales operations across pharmacy, telemedicine, and direct-to-consumer channels.

Management highlighted first-half fiscal 2026 results of $17.8M revenue, $1.4M net income, $1.18M operating cash flow, and gross margins >70%; Hayden IR cited operating leverage and CEO alignment (over 122M shares held).

Earth Science Tech (OTC: ETST) announced that the Financial Industry Regulatory Authority processed a Form 211 filed by a sponsoring broker-dealer on Dec 12, 2025, clearing the broker-dealer to initiate priced quotations for ETST within four days of Dec 12, 2025. The company described this clearance as a strategic milestone expected to help build long-term shareholder value, improve liquidity, and increase visibility for its business plan. The release notes that FINRA's processing of Form 211 does not constitute FINRA approval of the security, the issuer, or the issuer's business and relates solely to the broker-dealer's compliance with applicable FINRA and SEC rules.

Earth Science Tech (OTC: ETST) reported strong Second Fiscal Quarter results for the period ended September 30, 2025. Key financials: Total Assets $8.66M (+71.64% YoY, +22.65% YTD from $7.07M), Quarterly Revenue $9.05M (+6.24%), Gross Profit $6.72M (+7.3%), and Quarterly Net Profit $0.94M (+18.48%). Outstanding common shares fell to 292.8M, a 3.57% reduction YoY. Management described the quarter as execution of its strategy to acquire and scale high-potential operating businesses and cited asset growth and share reduction as evidence of shareholder-value focus.

Earth Science Tech (OTC: ETST) has significantly enhanced its share repurchase program, increasing the total authorization to $10 million and extending it through December 31, 2027. Since the program's inception in January 2024, ETST has already invested $1.83 million to repurchase 20.83 million shares.

The company currently has a remaining authorization of $8.17 million for future share repurchases. The program allows for discretionary repurchases through open market or private transactions, subject to market conditions and other factors, and can be suspended or discontinued at any time.

Earth Science Tech (OTC:ETST) announced its Board of Directors has approved a reduction in authorized common stock from 350 million to 300 million shares. The company currently has approximately 294.3 million shares outstanding.

CEO Giorgio R. Saumat emphasized that this strategic decision reflects the Board's confidence in the company's trajectory and demonstrates their commitment to preventing unnecessary shareholder dilution while protecting long-term shareholder value.

Earth Science Tech (OTC: ETST) reported significant growth in its first fiscal quarter ended June 30, 2025. The company's total assets increased 61% to $7.69 million, while revenue reached $8.7 million, up from $8.5 million year-over-year.

During the quarter, ETST executed several strategic acquisitions, including 100% acquisition of Las Villas Health Care and DOConsultation, along with 80% ownership of Magnefuse and Alicat (MagneChef Portfolio). The company reduced its outstanding shares by 4.78% to 294.3 million shares and maintained a cash position of $0.88 million after funding acquisitions.

Post-quarter developments include joining the OTCID Tier, expanding MisterMeds operations in Texas, and initiating Avenvi's first residential development project.

Earth Science Tech (OTC: ETST) has announced its qualification and listing on the new OTCID tier of OTC Markets, a designation that recognizes companies meeting enhanced disclosure, transparency, and compliance standards. The Company, which operates as a strategic holding company focused on acquiring and optimizing high-potential businesses, views this achievement as a reflection of its commitment to corporate governance and investor communication.

CEO and Chairman Giorgio R. Saumat highlighted the company's turnaround over the past two years. The company expects this new designation to enhance investor confidence and support its growth initiatives.

Earth Science Tech (OTC: ETST) has reported exceptional financial results for the fiscal year ended March 31, 2025. The company achieved significant growth across all key metrics, with revenue reaching $33.1 million, representing a remarkable 177.05% increase year-over-year.

The company's performance showed substantial improvements in profitability, with net profit surging by 300.63% to $3.2 million. Cash position strengthened by 111.15% to $1.47 million, while total assets grew by 82.07% to $7.07 million. Additionally, ETST reduced its outstanding shares by 4.72%, demonstrating commitment to shareholder value.

Earth Science Tech (OTST: ETST) has reported exceptional financial projections for FY ending March 31st, 2025, with projected net income of $3.6 million (340% YoY increase) and revenue of $32 million (175% YoY growth). The company's EPS is projected at $0.01, with total assets reaching $7.2 million (85% growth). Key developments include: expansion of Board to 7 members, qualification for OTCID listing, growth to 76 total employees, and repurchase of 15.6M shares under a $5M program. ETST made strategic acquisitions including Mister Meds, Avenvi, Las Villas Health Care, and Magnefuse. RxCompoundStore expanded to 24 states, while Peaks Curative launched Zoolzy for animal health. The company's subsidiaries span healthcare, real estate, and consumer retail sectors, positioning ETST for continued growth.